|1.||Robinson, Cynthia Y: 4 articles (09/2015 - 01/2014)|
|2.||Wen, Warren: 4 articles (07/2015 - 06/2012)|
|3.||Farr, Stephen J: 3 articles (09/2015 - 01/2014)|
|4.||Hale, Martin E: 3 articles (09/2015 - 01/2014)|
|5.||He, Ellie: 3 articles (07/2015 - 01/2015)|
|6.||Atayee, Rabia S: 3 articles (09/2014 - 05/2012)|
|7.||Best, Brookie M: 3 articles (09/2014 - 05/2012)|
|8.||Manchikanti, Laxmaiah: 3 articles (03/2014 - 07/2005)|
|9.||Moore, Paul A: 3 articles (08/2013 - 05/2006)|
|10.||Morris, E: 3 articles (08/2000 - 05/2000)|
01/01/2014 - "This single-entity, extended-release formulation of hydrocodone was generally safe, well tolerated, and effective in reducing chronic pain for 48 weeks. "
07/01/2007 - "Each patient received 0-40 mg/24hrs of hydrocodone as needed for pain relief for the duration of this four week study. "
01/01/2015 - "The recent introduction of extended-release formulations of the opioid analgesic hydrocodone potentially broadened the possibility of providing pain relief for individuals for whom current formulations are either ineffective or not tolerated. "
01/01/2008 - "An additional 14.5% of the patients responded to a double dose, and the remaining 29% of patients did not experience any pain relief from hydrocodone administration. "
09/01/2015 - "Patients with chronic pain newly enrolled or rolled over from a 12-week, placebo-controlled hydrocodone ER study; 330 patients enrolled, 329 patients received study drug, and 189 completed the study. "
06/01/2015 - "Rescheduling of hydrocodone combination products: potential impact and alternatives for postoperative pain management."
04/01/2015 - "Postoperative pain management was variable, with hydrocodone and derivatives given most commonly (61%). "
01/01/2006 - "Group A (N = 50) used hydrocodone to manage postoperative pain. "
05/01/2004 - "The use of a PCA ropivacaine infusion (group I) resulted in a significant reduction of postoperative pain by 34% as measured by VAS scale (P <.05), but no changes in the amount of hydrocodone consumption. "
06/01/2004 - "Efficacy of ibuprofen-hydrocodone for the treatment of postoperative pain after periodontal surgery."
09/01/2000 - "We reviewed the pharmacy records for the use of hydrocodone for all cancer admissions to our unit from May 1996 to December 1998. "
01/01/2002 - "Hydrocodone is effective and safe to treat cough in advanced cancer A starting dose of 10 mg per day in divided doses seems effective. "
03/01/2013 - "This study sought to characterize the experience of patients taking hydrocodone for non-cancer pain. "
01/01/2013 - "The available clinical trials for the use of hydrocodone in the management of acute, chronic, and cancer pain are presented."
01/01/2002 - "This study evaluates hydrocodone for cough in advanced cancer The results presented are from a phase II study with dose titration. "
02/15/2007 - "Although hydrocodone is widely used and has been shown to effectively treat cough caused by other conditions, the drug has not been studied in patients with colds. "
09/01/2004 - "Perception of cough by both the bronchoscopist and the nurse was significantly lower in the hydrocodone group (3 (0-10) and 3 (0-10)) than in the placebo group (6 (0-10) and 6 (0-10)), respectively (p = 0.001). "
09/01/2004 - "A randomised, placebo controlled, double blind study was undertaken to determine whether hydrocodone in combination with midazolan improves cough suppression during FB without increasing the risk of desaturation. "
01/01/2002 - "Cough severity, frequency, complications, and hydrocodone side effects. "
05/23/1986 - "Isolation and identification of hydrocodone in narcotic cough syrups by high-performance liquid chromatography with infrared spectrometric identification."
|5.||Low Back Pain (Lumbago)
06/01/2014 - "Single-entity hydrocodone extended-release capsules in opioid-tolerant subjects with moderate-to-severe chronic low back pain: a randomized double-blind, placebo-controlled study."
01/01/2015 - "This multicenter, randomized, double-blind, placebo-controlled study with an enriched enrollment, randomized withdrawal design was conducted to evaluate the analgesic efficacy and safety of single-entity, once-daily hydrocodone 20 to 120 mg tablets (HYD) in opioid-naive and opioid-experienced patients with uncontrolled moderate to severe chronic low back pain (CLBP). "
01/01/2015 - "A multicenter, randomized, double-blind, placebo-controlled trial to assess the efficacy and safety of single-entity, once-daily hydrocodone tablets in patients with uncontrolled moderate to severe chronic low back pain."
01/01/2015 - "Efficacy and tolerability of a hydrocodone extended-release tablet formulated with abuse-deterrence technology for the treatment of moderate-to-severe chronic pain in patients with osteoarthritis or low back pain."
06/01/2015 - "This study aimed to assess the tolerability of the extended use (≤35 days) of MNK-155, a biphasic (immediate-release/extended-release) hydrocodone bitartrate/N-acetyl-p-aminophenol (acetaminophen) (IR/ER HB/APAP) 7.5/325-mg fixed-dose combination analgesic agent, in patients with chronic noncancer pain (CNCP) caused by osteoarthritis or chronic low back pain. "
|3.||Codeine (Codeine Phosphate)
|7.||Opioid Analgesics (Opioids)
|9.||Analgesics (Analgesic Drugs)
|10.||Narcotics (Narcotic Analgesics)
|5.||Drug Therapy (Chemotherapy)